• Asian Pacific Journal of Cancer Prevention
• /
• 제16권3호
• /
• pp.1255-1258
• /
• 2015

Background: Locally advanced head and neck cancer is generally incurable and has a short survival rate. This study aimed to evaluate symptom relief, disease response, and acute toxicity after palliative hypo-fractionated radiotherapy and long-term survival in affected patients. Materials and Methods: Between January 2011 to December 2011, 80 patients who were histopathologically diagnosed as having stage III or stage IV head and neck squamous cell carcinoma based on Eastern Cooperative Oncology Group (ECOG) performance status 1-3, were offered palliative radiotherapy (20 Gy/5Fr/5 Days). Later these patients were evaluated on 30th day after completion of treatment for disease response based on World Health Organisation (WHO) criteria and palliation of symptoms using symptomatic response grading and acute toxicities by the Radiation Therapy Oncology Group (RTOG). Many patients were given post radiation therapy (RT) palliative chemotherapy for appropriate palliative care and a few patients were selected for further curative RT. The overall survival was also evaluated among this group of patients with last follow up date of 1st May, 2014. Results: The most common presenting complaint was pain followed by dysphagia. Most patients (60-70%) had appreciable relief in their presenting symptoms. A good response was observed in the majority following palliative RT; a few patients had progressive disease and some had stable and regressed disease. None of the patients experienced radiation toxicity that required hospital admission. Almost all showed grade one and two acute skin and mucosal toxicity one month after completion of treatment. The mean survival days for patients given only hypofractionated palliative RT was 307 days, those with post palliative RT and palliative chemotherapy was 390 days and patients who went on to receive further palliative RT and curative RT dose had significantly overall survival of 582 days. Conclusions: Advanced head and neck cancer should be identified for suitable palliative hypofractionated radiotherapy to achieve acceptable symptom relief in a great proportion of patients and should be followed by palliative chemotherapy or curative RT in suitable cases for long-term symptom-free survival.

• 대한한의학방제학회지
• /
• 제20권1호
• /
• pp.13-24
• /
• 2012

Objectives : Yukmijihwang-tang(Wan), a well-known formula for invigorating yin-particular kidney yin, was first recorded in "Xiao er Yao Zheng Zhi Jue", consisting of Radix Rehmanniae Preparata, Fructus Macrocarpii, Rhizoma Dioscoreae Oppositae, Poria, Rhizoma Alismatis and Cortex Moutan Radicis with dose proportion of 8:4:4:3:3:3. Although clinical trials have been lacking, various pharmacological actions for Yukmijihwang-tang has been identified newly using animal models. In addition, it was reported that Yukmijihwang-tang increases structural chromosome aberrations significantly in Chinese hamster lung cells. In this article, it is purposed that new studies for pharmacology and toxicology of Yukmijihwang-tang are reviewed. Insight into new studies of Yukmijihwang-tang at the cellular and animal levels will enhance our understanding of Yukmijihwang-tang against various diseases will provide new tools to diagnose and treat patients. Methods : Recent researches for Yukmijihwang-tang were reviewed and summarized in terms of pharmacological action and toxicity. All sources for review were based on recent studies loaded on data base of web sites such as Science Direct and National Center for Biotechnology Information. Results and Conclusions : Recently, reports showed that YMJ had antiaging effects, antioxidant and free radical scavenging activities, anti-renal hypertension and prevented tumors, and diabetes mellitus. However, there is little information on its safety except general toxicity, acute and sub-chronic oral toxicity, or genotoxicity. In addition, clinical trial for Yukmijihwang-tang was limited even though Yukmijihwang-tang has been used extensively in Korean traditional medicine. Thus, further studies are necessary to focus on safety evaluation and clinical trial for Yukmijihwang-tang.

• 한국식품영양과학회지
• /
• 제20권1호
• /
• pp.13-20
• /
• 1991

For this experiment frist the fermented Soybean Meju was prepared by domestic ordinary method of Korean and concentrated Meju suspensoidal extract was made for toxicological test sample on mice and rat. Even the oral dose of 10g extract per kg of mice had not any acute toxicity. So the median lethal dose(LOD50) is lilely to be much greatr or not to be. In comparison of the average weight gain rate for 4 weeks the control and test groups of 0.308g Ex/rat kg and 9.24g Ex/rat kg daily were the much the same as about 19% but 3.08g Ex/rat kg group waas exceptionally 2.7% higher than control For this period all test groups did not show any abnormality in appearance and anatomic findings. In serum GPT GOT alkaline phosphatase and blood urea nitrogen value there were no difference significantly between control and the test groups of 0.308g/rat kg and 3.08g/rat kg but 9.24g/rat kg group was some what higher than control. Especially in cholesterol alkaline phosphatase and blood urea nitrogen value 9.24g/rat kg group or 28days had 100mg/이 37.5u 32mg/이 respectively which were increased significantly. The pathological findings of all test groups especially 9.24g/kg group did not showed any characterized sign of acute or subacute liver damage or intestine lesion. So it is supposed that there is not any tocixants originated from some molds in fermented Korean domestic Meju which is prepared traditionally in winter.

• 농약과학회지
• /
• 제17권4호
• /
• pp.343-349
• /
• 2013

식물추출물 후추 추출물과 카시아 오일, 라벤더 오일을 이용하여 친환경유기농자재로 개발 중인 제품으로 배추좀나방 방제에 이용할 수 있는 후추 추출물+카시아 오일 57.5% (후보제형 A), 후추 추출물+카시아 오일 57% (후보제형 B), 후추 추출물+라벤더 오일 50% (후보제형 C) 유제의 생태에 대한 급성독성을 평가하여 친환경농자재 시제품으로서의 활용가능성을 확인하고자 하였다. 물벼룩 급성독성을 실시한 결과 후보제형 A 및 C 유제의 $EC_{50}$은 각 0.46, 0.25 mg $L^{-1}$로 EPA 기준으로 강한 독성이었고, 후보제형 B 유제의 $EC_{50}$는 1.9 mg $L^{-1}$로 보통독성이었다. 잉어 급성독성 시험의 경우, 후보제형 A 유제의 $LC_{50}$가 1.9 mg $L^{-1}$으로 농촌진흥청 고시에 따라 어독성 II급 농약이었으며 후보제형 B, C 유제는 2.9, 3.8 mg $L^{-1}$로 어독성 III급 농약으로 구분되었다. 꿀벌 급성독성시험은 접촉과 섭식 시험으로 나누어서 실시하였고, 후보 3종 모두 접촉과 섭식독성 $LD_{50}$가 100 ${\mu}g$ a.i $bee^{-1}$ 이상으로 나타나 독성이 낮은 것으로 판단되었다. 지렁이 급성독성시험의 경우, 후보제형 A, B 및 C 유제의 $LC_{50}$가 각각 887, 988, 564 mg $kg^{-1}$이었다. 후추 추출물+카시아 오일 57% (후보제형 B), 후추 추출물+라벤더 오일 50% (후보제형 C) 유제는 어독성 및 꿀벌 급성독성이 낮아 친환경 농자재로서 활용이 가능할 것으로 사료되었다.

• 약학회지
• /
• 제39권6호
• /
• pp.671-675
• /
• 1995

The bark of Ulmus davidiana var. japonica(Ulmaceae) has been described in traditional books to have diuretic and laxative actions, to ameliorate edematous disease, and to be used in insomnia and gastointestinal disorders. Thus this study was carried out to elucidate some of the pharmacological activities of the plant extracts. The results obtained in tills experiment indicated that its methanol extract elicited remarkable inhibition of HCI.ethanol induced gastric lesion, Shay ulceration and gastric secretion. However, it showed no anti-inflammatory action. The acute toxicity of the extract was low, that is, the minimum lethal dose was more than 2000 mg/kg by oral administration in mice. The systematic fractionation of the methanol extract by hexane, ether, ethylacetate and butanol resulted in potent prevention of gastric erosion in butanol and water fractions.

• Biomolecules & Therapeutics
• /
• 제7권3호
• /
• pp.221-226
• /
• 1999

In this study, 75% ethanol extract from the flowers of Carthamus tinctorius was prepared and biological activities were examined. The extract showed the inhibitory activity of vascular smooth muscle contraction and antithrombotic activity judged by bleeding time measurement. It also showed anti-inflammatory and potent analgesic activities in vivo. By oral administration of the extract, no acute toxicity was observed up to 5 g/kg in mice and rats. All these results strongly suggest that this extract may be beneficial for postmenopausal disorder by enhancing blood circulation.

• 사상체질의학회지
• /
• 제9권2호
• /
• pp.203-225
• /
• 1997

Jihwangbakhotang(地黃白虎楊) is made by Li Je Ma, the creator of the Four Constitutional Medicine. Single and 13 weeks oral repeated dose toxicity studies were conducted in Sprague Dawley rats of both sexes to elucidate the potential acute and subchronic toxicity of JBT extract and reversibility of any effects. In the single dose study, JBT extract was administered orally to rats with the dose of 2 g/kg and 8 g/kg. In the long term administration of 13 weeks, the JBT extract of 125 mg/kg/day, 500 mg/kg/day, 2000 mg/kg/day was administered to rats. The change of blood weight, urine volume, electrolyte in urine, hematological change, the change of blood chemistry, autopsy finding, and histological observation were researched, the results were as follows; 1. The lethal dose of JBT extract seems to be over 10 g/kg, the single administration of JBT extract 8 g/kg showed no toxical signs except little increase of urine volume. 2. The change of body weight had the trend of decrease in the group of, but has no significance, and also the consumption of food and water had no changes. 3. The hematological changes induced by the 13 weeks administration of JBT extract showed the significance in the item of Hb, MCH, MCV, WBC in the group of 125 mg/kg/day. 4. In the test of blood chemistry, total cholesterol showed little decrease and A/G ratio showed little increase, but the change was not clear, and the standard error was large. So the result was obtained insignificantly and the toxicity of JBT extract was not observed. 5. In the male group after recovery period, the level of cholesterol and triglyceride decreased slightly, but the result was not significant. 6. In the urine test, the little change of electrolyte was appeared, but it seemed not to be the result induced by the toxicity of JBT extract. 7. In each group of male and female rats, the weight change of organ and the serum histological changes was observed, but the result did not showed the dose dependent toxicity. So the toxicity of JBT extract was not regarded. In the conclusion, the toxicity of JBT extract was not observed in the single dose treatment and long term repetitive administration of JBT extract.

• 한국식품저장유통학회지
• /
• 제20권1호
• /
• pp.121-126
• /
• 2013

본 연구는 김치에서 분리한 우수한 항균활성을 나타내는 Leuc. citreum GR1을 분리하여 단기투여에 의한 안전성을 확인하고자 식품의약품안전청의 의약품 등의 독성시험기준에 따라 실시하였다. 시험물질인 Leuc. citreum GR1의 임상적용 경로가 구강이므로 경구투여용 존데를 사용하여 단회 경구 투여를 수행하였으며, 투여용량은 단회 경구투여 최고용량인 5,000 mg/kg을 고농도로 설정하였다. 급성독성시험을 위하여 경구 1회 시험물질을 625, 1,250, 2,500 및 5,000 mg/kg 투여 용량으로 하여 ICR계 암 수 마우스에게 용량별 각 군당 10마리씩 시험물질을 투여한 후 14일간의 일반증상, 사망률, 체중, 임상증상 및 육안적 소견을 관찰하였다. 단회 경구투여한 후 모든 시험군에서 사망례가 관찰되지 않았으며, 시험동물은 시험 종료 시까지 계속 생존하여 평균치사량을 산출할 수 없었다. 경구투여한 후 마우스의 체중변화에 있어서도 암 수 모두 대조군과 시료물질 투여군 사이에 유의성 있는 차이는 보이지 않았으며, 용량 의존적인 차이도 볼 수 없었다. 단회 경구구투여 후 시험 종료한 다음 생존동물 모두를 부검하여 주요 장기의 육안적 소견을 관찰한 결과 대조군과 시료투여군 모두에서 외관상이나 내부 장기에 어떠한 이상소견이나 병변이 관찰되지 않았다. 이상의 결과로부터 시험물질인 Leuc. citreum GR1는 경구투여 시 ICR계 암 수 마우스에서 독성학적인 변화가 관찰되지 않았으며, 경구투여가 5,000 mg/kg 이상인 저독성의 안전한 물질로 사료된다.

• 농약과학회지
• /
• 제15권4호
• /
• pp.350-356
• /
• 2011

최근에는 화학적 살충소재 보다 친환경적인 살충소재를 선호하여 천연물질을 함유한 친환경 살충제의 개발이 활발히 이루어지고 있다. 본 연구의 목적은 해충 방제에 이용할 수 있는 친환경 농자재인 식물정유(싸임화이트, 클로브버드, 계피, 라벤더, 레몬유칼립투스)의 생태독성을 평가하는 것이다. 생태독성 평가로 물벼룩(Daphina magna), 송사리(Oryzias latipes), 꿀벌(Apis mellifera L.), 지렁이(Eisenia fetida)를 이용하였다. 물벼룩급성독성시험의 경우, 싸임화이트, 클로브버드, 계피 정유의 $EC_{50}$ 값은 각각 2.5, 2.8, $6.9mg\;L^{-1}$로 EPA 기준으로 보통독성정도이었고, 라벤더, 레몬유칼립투스 정유는 $10mg\;L^{-1}$ 이상이었다. 송사리급성독성 시험의 경우, 싸임화이트와 계피 정유의 $LC_{50}$ 값이 6.7, $7.5mg\;L^{-1}$으로 나타났으며 나머지 정유는 모두 $10mg\;L^{-1}$으로 확인되었다. 꿀벌급성독성시험은 접촉과 섭식 시험으로 나누어서 실시하였고, 모든 정유의 $LD_{50}$ 값이 $100{\mu}g$ a.i $bee^{-1}$ 이상으로 확인되었다. 지렁이급성독성시험의 경우, 싸임화이트, 클로브버드, 계피, 라벤더, 레몬유칼립투스의 $LC_{50}$ 값이 각각 149, 230, 743, 234, $635mg\;kg^{-1}$로 나타났다. 결과적으로 식물 정유들의 지렁이급성독성에 대한 안전성이 확인될 경우 환경에 대한 안전성이 확보된 친환경 살충소재로서의 활용 가능성이 예상되며, 친환경 농자재 생산에 기여할 것으로 사료된다.

• Asian Pacific Journal of Cancer Prevention
• /
• 제15권10호
• /
• pp.4147-4152
• /
• 2014

Standard therapy for advanced head and neck cancer consists of a combination of surgery and radiation. However, survival of this patient population has not improved during the past 20 years. Many different multimodality treatment schedules have been proposed, and chemotherapy is often used with the intent of organ preservation. The present study was intended to establish the efficacy of concomitant chemoradiation with a single agent carboplatin in advanced head and neck cancers.The objectives were to investigate the feasibility of concomitant administration of carboplatin, monitor acute toxicity during radiotherapy, and determine subacute side effects, such as wound healing following surgery after chemoradiotherapy. A prospective study was conducted wherein a total of 40 patients with stage III and IV squamous cell carcinomas of oral cavity, oropharynx, hypopharynx and larynx were enrolled. All patients were treated with external beam radiotherapy and weekly carboplatin area under curve (AUC of 5). Radiotherapy was given in single daily fractions of 1.8-2 grays (Gy) to a total dose of 66-72 Gy. Salvage surgery was performed for any residual or recurrent locoregional disease. Neck dissection was recommended for all patients with neck disease showing less than a complete response after chemoradiation. A total of 40 patients were enrolled of whom 32 were males and 8 were females. Highest incidence of cancer was seen in the 5th-6th decades of life with a median age of 47.7 years. Oropharyngeal tumours constituted a maximum of 21 patients followed by hypopharynx in 10, larynx in 7 and oral cavity in 2. 80% of the patients had a neck node on presentation of which 40% had N2-N3 nodal status. TNM staging revealed that 58% of patients were in stage III and 43% in stage IV. Evaluation of acute toxicity revealed that 50% had grade II mucositis, 25% grade III mucositis, 2.5% grade IV mucositis. 50% of patients had grade I skin reactions, 65% of patients had grade I thrombocytopenia, and 24% of patients had grade I anaemia. After completion of treatment 65% of patients had complete response at the primary and regional sites, and 35% of patients had a partial response of whom 23% underwent neck dissection and 5% of them underwent salvage surgery at the primary site. At the end of one year there were six deaths and four recurrences and 70% were free of disease. Concurrent chemoradiation with carboplatin provided good locoregional control for locally advanced head and neck cancers. This regimen, although toxic, is tolerable with appropriate supportive intervention. Primary site conservation is possible in many patients. Chemoradiotherapy appears to have an emerging role in the primary management of head and neck cancers.